Integrating palliative care into self-management of breast cancer: Protocol for a pilot randomized controlled trial.
Integrating palliative care into self-management of breast cancer: Protocol for a pilot randomized controlled trial.
复制标题
将姑息治疗纳入乳腺癌的自我管理：试点随机对照试验方案。
DOI：
10.1016/j.cct.2016.04.009
复制
发表时间：
2016
影响因子：
2.2
通讯作者：
Chagpar,Anees
中科院分区：
文献类型：
--
作者：
Schulman-Green,Dena;Linsky,Sarah;Jeon,Sangchoon;Kapo,Jennifer;Blatt,Leslie;Chagpar,Anees
尽管有证据表明姑息治疗可以提高生活质量和延长生命，但许多患者和家属仍然不了解姑息治疗的性质和益处。本研究的目的是测试一种心理教育干预，管理癌症护理：一个人的指南（MCC），旨在提高乳腺癌患者的姑息护理知识，并促进其及时融入癌症自我管理。2）检查MCC对患者行为的初步影响（在自我管理中的作用，参与护理对话的目标，医疗沟通，过渡管理，医疗保健利用）和感受（自我效能、焦虑、抑郁、不确定性）; 3）评估方案的可行性和可接受性。一个探索性的目的是调查人口统计学和临床因素可能如何调节干预效果，重点是少数参与者在使用和结果方面的差异。我们计划招募60名患者及其家庭护理人员，其中50%为少数民族参与。干预组接受MCC;注意力控制组接受症状管理工具包。我们收集数据，在基线，一，三months.DiscussionThis研究将通知MCC的大规模试验。对于乳腺癌患者，他们的家庭护理人员和提供者来说，做出选择是具有挑战性的，包括单独的姑息治疗或与潜在的治愈性治疗相结合。MCC可以通过为患者提供更好地自我管理乳腺癌的信息，技能和信心来帮助应对这一挑战。结果可能有助于将姑息治疗确立为针对严重疾病的自我管理干预措施的支柱。试验registrationClinicalTrials.gov标识符NCT 02148575（注册日期：2014年5月21日;首例患者入组日期：2014年7月15日）
BackgroundDespite evidence that palliative care increases quality and length of life, many patients and families remain uninformed about its nature and benefits. The purpose of this study is to test a psycho-educational intervention,Managing Cancer Care:A Personal Guide(MCC), intended to improve breast cancer patients' knowledge of palliative care and to facilitate its timely integration into cancer self-management.MethodsAims are to: 1) evaluate the effects of MCC on patients' knowledge of palliative care; 2) examine preliminary effects of MCC on patients' behaviors (role in self-management, engagement in goals of care conversations, medical communication, management of transitions, health care utilization), and feelings (self-efficacy, anxiety, depression, uncertainty); and 3) evaluate protocol feasibility and acceptability. An exploratory aim is to investigate how demographic and clinical factors may moderate intervention effects, with emphasis on differences in use and outcomes among minority participants. We plan to enroll 60 patients and their family caregivers with 50% minority participation. The intervention group receives MCC; the attention-control group receives a Symptom Management Toolkit. We collect data at baseline, one, and three months.DiscussionThis study will inform a large scale trial of MCC. It is challenging for patients with breast cancer, their family caregivers, and providers to make choices that include palliation alone or in combination with potentially curative treatment. MCC may help address this challenge by giving patients the information, skills, and confidence to better self-manage breast cancer. Results may help to establish palliative care as a mainstay of self-management interventions targeting serious illness.Trial registrationClinicalTrials.gov Identifier NCT02148575 (date registered: 5.21.14; datefirst patient enrolled: 7.15.14)